Periodic Reporting for period 3 - OrganoPlate Graft (Organ-on-a-Chip technology for in vitro grafting and vascularisation of 3D tissues)
Période du rapport: 2021-09-01 au 2022-02-28
SOLUTION – The OrganoPlate® Graft project involved the development to market readiness of the first high-throughput in vitro culture system for vascularized tissue that is unrivalled in biological performance, speed and ease of use. An extensive proof of concept (PoC) for this method has been obtained. The new product will be launched within 6-months post-project and allow for the study and manipulation of human tissues with functional human vascularization at an industrial scale and quality.
RESULTS – The aimed result of the 3-year OrganoPlate® Graft project was to empower users by aiding them to grow tissues with human vascularization in vitro – enabling a dramatic reduction in the need for animal experiments and enabling the design of completely novel experiments in research, development, and clinical settings. This is expected to aid the development of better drugs at a reduced financial and ethical cost. We established the OrganoReady Vascular Bed product, with a finalized manufacturing strategy implemented and roll out of the beta testing program. The first shipments to customers have been successfully executed and customer application developments have initiated. One of our showcase applications is currently under peer review.